{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:55:12Z","timestamp":1765878912611,"version":"3.48.0"},"reference-count":32,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Child Neurology Society"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pathogenic\n                      <jats:italic>CYFIP2<\/jats:italic>\n                      variants cause developmental and epileptic encephalopathy (DEE), characterized by early\u2010onset intractable epilepsy and developmental delay. The disease course has not been delineated. Codon Arg87 is a de novo mutational hotspot associated with a severe DEE phenotype via gain\u2010of\u2010function mechanisms. Currently, there are no targeted therapies for\n                      <jats:italic>CYFIP2<\/jats:italic>\n                      \u2010related DEE. Genetic therapies initiated at early symptomatic stages have demonstrated benefit in other disorders and may be an important consideration for this patient population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We describe a child with a de novo\n                      <jats:italic>CYFIP2<\/jats:italic>\n                      Arg87Cys variant and a unique clinical course, along with a comprehensive literature review of reported cases. We identified 41 additional patients with pathogenic or likely pathogenic\n                      <jats:italic>CYFIP2<\/jats:italic>\n                      variants.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The Arg87Cys variant was present in 12\/42 (29%) patients. An additional 27 variants are described across 30 patients. All individuals had global developmental delay, 32\/42 (76%) developed epilepsy, and 25\/42 (60%) experienced seizure onset in the first year of life. Of those with seizures, 16\/32 (50%) had epileptic spasms, and 5\/32 (16%), including our patient, developed other seizure types before epileptic spasm onset. Interestingly, our patient is the only report of developmental and electroencephalographic (EEG) normalization after initial seizure onset and before spasms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Our patient expands the phenotype of\n                      <jats:italic>CYFIP2<\/jats:italic>\n                      \u2010related DEE by demonstrating developmental and EEG normalization after seizure onset and before onset of epileptic spasms and global developmental delay. Given the growing field of genetic therapies and other precision medicines, this period of normalization may represent a window of opportunity for future early intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/cns3.70036","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:46:43Z","timestamp":1761817603000},"page":"314-323","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expanding the Phenotype of\n                    <i>CYFIP2\u2010<\/i>\n                    Related Developmental Epileptic Encephalopathy: Case Report and Literature Review"],"prefix":"10.1002","volume":"3","author":[{"given":"Michaela","family":"Squire","sequence":"first","affiliation":[{"name":"Department of Neurology University of North Carolina Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jenna K.","family":"Lea","sequence":"additional","affiliation":[{"name":"Department of Neurology University of North Carolina Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng (Jane)","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology University of North Carolina Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3655-0560","authenticated-orcid":false,"given":"Senyene E.","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Neurology University of North Carolina Chapel Hill North Carolina USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09623"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25208"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41436-020-01011-x"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.2174\/1874205X\u2010v16\u2010e2203290"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017749"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0331-z"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2024.104302"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9061355"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33174-3"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad349"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2025.04.010"},{"key":"e_1_2_11_13_1","unstructured":"J.Sullivan A.Desukar J.Schreiber et al. \u201cMONARCH and ADMIRAL: Phase 1\/2a Studies in US and UK Investigating Safety and Drug Exposure of STK\u2010001 an Antisense Oligonucleotide (ASO) in Children and Adolescents With Dravet Syndrome (DS)\u201d [Internet] 2023 https:\/\/aesnet.org\/abstractslisting\/monarch\u2010and\u2010admiral\u2010phase\u20101\u20102a\u2010studies\u2010in\u2010us\u2010and\u2010uk\u2010investigating\u2010safety\u2010and\u2010drug\u2010exposure\u2010of\u2010stk\u2010001\u2010an\u2010antisense\u2010oligonucleotide\u2010aso\u2010in\u2010children\u2010and\u2010adolescents\u2010with\u2010dravet\u2010syndrome\u2010ds."},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.06.007"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-022-00941-1"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2022.04.006"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0868-8"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12030479"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.18338"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019\u20103449"},{"key":"e_1_2_11_21_1","unstructured":"San Francisco CA IC. \u201cInvitaeEpilepsy Panel\u201d 2023 https:\/\/www.invitae.com\/us\/providers\/test\u2010catalog\/test\u201003401."},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2015.07.008"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2021.106631"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000001101"},{"key":"e_1_2_11_25_1","unstructured":"Cincinnati Children's Hospital Medical Center Cincinnati OH MGL. \u201cNeutropeniaGene Sequencing Panel\u201d [Internet] https:\/\/www.cincinnatichildrens.org\/\u2010\/media\/Cincinnati\u2010Childrens\/Home\/service\/d\/dchi\/default\/im\u20105007_5\u201014\u2010inherited\u2010neutropenia\u2010panel.pdf."},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.63478"},{"key":"e_1_2_11_27_1","first-page":"426","article-title":"A Girl With Intractable Epilepsy and Intellectual Developmental Disorder Due to a Novel CYFIP2","volume":"54","author":"Hamaguchi M.","year":"2022","journal-title":"No To Hattatsu [Brain and Development]"},{"issue":"2","key":"e_1_2_11_28_1","article-title":"Clinical Role of Codon 87 of the CYFIP2 Gene in Early Infantile Epileptic Encephalopathy: A Clinical Case Description","volume":"15","author":"Da Silva Cardoso J.","year":"2023","journal-title":"Cureus"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-014-8775-9"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1063703"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2012.00313.x"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2653"},{"issue":"1","key":"e_1_2_11_33_1","first-page":"77","article-title":"Expression Atlas Update: From Tissues to Single Cells","volume":"48","author":"Papatheodorou I.","year":"2020","journal-title":"Nucleic Acids Research"}],"container-title":["Annals of the Child Neurology Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cns3.70036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:50:26Z","timestamp":1765878626000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cns3.70036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1002\/cns3.70036"],"URL":"https:\/\/doi.org\/10.1002\/cns3.70036","archive":["Portico"],"relation":{},"ISSN":["2831-3267","2831-3267"],"issn-type":[{"type":"print","value":"2831-3267"},{"type":"electronic","value":"2831-3267"}],"subject":[],"published":{"date-parts":[[2025,10,30]]},"assertion":[{"value":"2025-07-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}